NOVA Phase III trial of niraparib in platinumsensitive ovarian cancer patients

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=btoYfqpD2ac

Nicoletta Colombo, MD, PhD from the European Institute of Oncology (IEO), Milan, Italy gives an overview of the Phase III ENGOT-OV16/NOVA trial of niraparib ...

Medicines: Niraparib, Subject: Gynecological Cancer, ovarian cancer, BRCA mutations, Trial: ENGOT-OV16/NOVA, PARP inhibitor, Speaker: Nicoletta Colombo, Event: ESMO 2016, gBRCA, non-gBRCA, NCT01847274, platinum-sensitive
#############################